Patents by Inventor Martin Pitschke

Martin Pitschke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6498017
    Abstract: A method for the diagnostic detection of diseases associated with protein depositions (pathological protein depositions) by measuring an association of substructures of the pathological protein depositions, structures forming pathological protein depositions, structures corresponding to pathological protein depositions and/or pathological protein depositions as a probe; to substructures of the pathological protein depositions structures forming pathological protein depositions, structures corresponding to pathological protein deposition and/or pathological protein depositions as targets; characterized in that the target is detected in liquid phase wherein, in the case of detecting Alzheimer's disease, the liquid phase is obtained from body fluids or is itself a body fluid; with the proviso that the association of the probe to the target is measured before self-aggregation of the probe predominates.
    Type: Grant
    Filed: May 22, 2000
    Date of Patent: December 24, 2002
    Assignee: Evotec Biosystems AG
    Inventors: Detlev Riesner, Karin Post, Oliver Schaefer, Martin Pitschke, Manfred Eigen, Jan Bieschke
  • Publication number: 20020042121
    Abstract: A method for the diagnostic detection of diseases associated with protein depositions (pathological protein depositions) by measuring an association of substructures of the pathological protein depositions, structures forming pathological protein depositions, structures corresponding to pathological protein depositions and/or pathological protein depositions as a probe; to substructures of the pathological protein depositions, structures forming pathological protein depositions, structures corresponding to pathological protein depositions and/or pathological protein depositions as targets; characterized in that the target is detected in liquid phase wherein, in the case of detecting Alzheimer's disease, the liquid phase is obtained from body fluids or is itself a body fluid; with the proviso that the association of the probe to the target is measured before self-aggregation of the probe predominates.
    Type: Application
    Filed: May 22, 2000
    Publication date: April 11, 2002
    Inventors: DETLEV RIESNER, KARIN POST, OLIVER SCHAEFER, MARTIN PITSCHKE, MANFRED EIGEN, JAN BIESCHKE